New Biotech Stocks Added to Investor Ideas Directory; (NASDAQ: $AZRX), (OTC:
$ASDS), (NYSE: $AUXO)
Point Roberts, WA, Delta BC – April 28, 2017 –
Investorideas.com, a global news source and investor resource covering actively
traded sectors announces this week’s additions to its investor membership, including global stock directories in biotech, technology and mining.
Investorideas.com tracks companies in high profile
trading sectors and makes ongoing additions to its stock directories for each
sector. Listing for the stock directories include companies on the
TSX, OTC, NYSE, NASDAQ and global stock exchanges.
This week’s biotech additions include a company
developing recombinant
proteins for the treatment of gastrointestinal diseases and microbiome related
conditions; an investment firm that acquires and manages community-based pharmacies
and a tech company that provides IT security to the healthcare industry.
Investorideas.com
global stock directories are part of the membership program on the site,
accessed either by login and password or available in PDF format. The
directories include stocks trading on the TSX, OTC, NASDAQ, NYSE and other
recognized global stock exchanges, giving retail investors a wide variety of
stocks to review. http://www.investorideas.com/membership/
The directories are not meant as recommendations
but as a research tool to discover opportunities and trading ideas in a particular
sector.
Read this release in full at
About
Investorideas.com - News that Inspires Big Ideas
Investorideas.com is a meeting place for global
investors, featuring news, stock directories, video, podcasts, company
profiles, interviews and more in leading sectors.
Sectors we cover include
tech, bitcoin and blockchain, biotech, mining, energy, renewable energy, water
stocks, marijuana and hemp stocks, food and beverage (including organic and
LOHAS, wine), defense and security (including biometrics), Latin America, sports,
entertainment, luxury brands and gaming.
The Investorideas.com content portfolio goes beyond
the www.investorideas.com site to include 12
blogs on Blogger.com, 7 Artificial Intelligence (AI) websites on the Grid
and the Waternewswire.com, all featuring Investorideas.com news and content.
Investor Ideas Directories for global investors:
From water stocks to gold and mining stocks,
renewable energy, nanotech, defense, technology, biotech and more – use our
stock directories and access them online 24/7 with login as a member to find
your next big idea!
Investorideas.com CSE service provider directory
listing: http://thecse.com/en/services/services-for-listed-companies
Disclaimer/Disclosure:
Investorideas.com is a digital publisher of third party sourced news, articles
and equity research as well as creates original content, including video,
interviews and articles. Original content created by investorideas is protected
by copyright laws other than syndication rights. Our site does not make
recommendations for purchases or sale of stocks, services or products. Nothing
on our sites should be construed as an offer or solicitation to buy or sell
products or securities. All investment involves risk and possible loss of
investment. This site is currently compensated for news publication and
distribution,social media and marketing, content creation and more. Contact
each company directly regarding content and press release questions. Disclosure
is posted for each compensated news release, content published /created if
required but otherwise the news was not compensated for and was published for
the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Additional info regarding BC Residents and global
Investors: Effective September 15 2008 - all BC investors should review all OTC
and Pink sheet listed companies for adherence in new disclosure filings and
filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to
regulations of each country.
Contact Investorideas.com
800-665-0411
No comments:
Post a Comment